Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Avoid hazardous reagents and -78°C conditions with this scalable 2,8-dioxaspiro[4.5]decan-1-one synthesis. 92% yield, 84% purity. Reduce supply chain risks.
Solve arylstannane synthesis challenges with 95% yields, no metal catalysts, and room-temperature processing. Reduce costs and supply chain risks for pharmaceutical intermediates.
Solve supply chain risks with this metal-free, high-yield synthesis. NINGBO INNO PHARMCHEM scales 3-hydroxymethyl-4-phenyl-3,4-dihydroquinolinone for pharma R&D and production.
Eliminate heavy metal residues and high costs in 3-hydroxy-2-indolone production with this novel metal-free synthesis method. Scale up efficiently with our CDMO expertise.
Eliminate metal catalysts and high-pressure hydrogenation risks in PF-06651600 synthesis. Our scalable, high-yield route ensures 99% purity and supply chain stability for alopecia areata treatments.
Solve supply chain risks with this novel 5-trifluoromethyl imidazole synthesis. 99%+ purity, scalable to 100MT/yr, and 95%+ yield. Contact for custom synthesis.
Discover a scalable indolocyclopentane synthesis method with >95% yield and 93% ee. Ideal for pharmaceutical R&D teams seeking cost-effective, high-purity intermediates for prostate cancer drug development.
Discover a novel 5-trifluoromethyl-1,2,4-triazole synthesis method eliminating heavy metal catalysts and anhydrous conditions. Reduce production costs and supply chain risks for your API manufacturing.
Discover a scalable, high-yield synthesis of N-axis chiral indole amides with >95% ee and potent Hep G2 cytotoxicity. Reduce R&D costs and supply chain risks with our CDMO expertise.
Solve Z/E isomer challenges in ketoxime synthesis with a cost-effective, base-free method. Achieve >98% Z-configuration purity and 60% yield for scalable pharmaceutical production.
Solve low-yield indanone synthesis challenges with gold-catalyzed method. 70-82% yields, no CO, scalable for API production. Contact for CDMO solutions.
Boost enantioselectivity in alpha-hydroxy-beta-keto ester synthesis with our large steric hindrance catalysts. Reduce costs, ensure GMP compliance, and scale efficiently. Contact us for custom synthesis.
Avoid toxic reagents and costly impurities in cinacalcet production. Our scalable, eco-friendly process ensures 99.7% purity and supply chain stability for pharma R&D.
Solve azaspiro[4,5]-tetraenone synthesis challenges with metal-free, scalable route. Reduce costs, avoid heavy metals, and ensure 99%+ purity for pharma intermediates.
Solve metal catalyst removal challenges in 3-phenyl-triazolo-pyridine synthesis. Our metal-free process ensures 80-96% yield, GMP compliance, and cost savings for cancer drug development.
Discover how metal-free synthesis of 4-polyfluoroalkyl-2,6-diaryl pyridines reduces production costs and supply chain risks for pharmaceutical intermediates. 100% patent-based insights.
Discover how DDQ-catalyzed metal-free oxidation of propargyl alcohol solves supply chain risks and cost issues in ynone synthesis for pharmaceuticals.
Solve thienoindole synthesis challenges with nickel-catalyzed route: 96% yield, no strong acids, simplified purification. Scale to 100MT/yr with CDMO expertise.
Discover metal-free alpha-carboline synthesis with 99% yield. Eliminate transition metal residues and streamline your pharma supply chain. Contact us for custom production.
Solve high catalyst costs and low yields in triazole synthesis. Our CDMO expertise scales this bimetallic process for 92%+ purity, reducing your supply chain risks.